Investors are a little more bearish on the company recently at least if you consider the increase in short interest. The firm realized a rise in short interest of 6.44% between September 29, 2017 and October 13, 2017. Short shares grew 89,861 over that period. The days to cover increased to 7.0 and the percentage of shorted shares was 0.04% on October 13.
These funds have shifted positions in (ANGO). Ls Investment Advisors, LLC added to its investment by buying 223 shares an increase of 20.1% in the quarter. Ls Investment Advisors, LLC now holds 1,331 shares worth $23,000. The total value of its holdings increased 27.8%. As of quarter end Strs Ohio had disposed of a total of 2,300 shares trimming its stake by 5.1%. The value in dollars went from $731,000 to $731,000 decreasing 0.0% quarter to quarter.
As of the end of the quarter First Quadrant L P/ca had sold 57,304 shares trimming its holdings by 51.0%. The value of the investment in (ANGO) decreased from $1,823,000 to $943,000 a change of $880,000 quarter over quarter. As of quarter end Peregrine Capital Management Inc /mn/ had sold a total of 197,693 shares trimming its position 26.4%. The value of the total investment in AngioDynamics, Inc. decreased from $12,133,000 to $9,413,000 a change of 22.4% since the last quarter.
The company is now up since yesterday’s close of $16.97. Company shares last traded at $16.97 which is just under the 50 day moving average of $17.39 and a tad above the 200 day moving average of $16.43. The 50 day moving average was down $-0.42 and the 200 day average was up $0.54.
AngioDynamics, Inc.’s P/E ratio is 171.41 and the market value is 623.05M. In the last earnings report the EPS was $0.10 and is estimated to be $0.66 for the current year with 36,715,000 shares currently outstanding. Next quarter’s EPS is forecasted to be $0.17 and the next full year EPS is anticipated to be $0.74.
AngioDynamics, Inc., launched on July 30, 1992, designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Business’s devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery..